OpenVSafe by OpenVAERS
Search V-safe

BBU-19472-03470

3 vaccinations 1 coded response 11 check-ins 1 free-text entry 2 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
711 / LA
Registered
2021-01-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-26
    Registered in v-safe
  3. 2021-01-26
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-26
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-01-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-07-29
    Survey response — 6 months, dose 2
    MedDRA: Graves' disease — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Graves Disease
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  11. 2021-07-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-08-05
  13. 2021-10-08
    Dose 3 — Pfizer-BioNTech
  14. 2021-10-08
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Nausea, Vomiting, Abdominal pain · Be unable to work or attend school
    Adult check-in
  16. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  17. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Adult check-in
  18. 2021-10-13
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  19. 2021-10-18

Vaccinations

DoseDateManufacturerCo-administered
12021-01-05Pfizer-BioNTech
22021-01-26Pfizer-BioNTech
32021-10-08Pfizer-BioNTech No

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

Release 9 — 6 months, dose 2

2021-07-29

Symptoms: Graves Disease

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGraves' disease ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release